Stromal Sarcomas
Links shared publicly online about this topic
Prostatic Stromal Sarcoma: eMedicine Pathology
emedicine.medscape.com — “Overview: Definition Prostatic stromal sarcoma is a rare malignant neoplasm that is believed to originated from specialized stromal prostatic cells.1, 2, 3, 4 At present, there is still debate on its specific definition, pathology, and prognosis.3This tumor ...” View full resource at emedicine.medscape.com
Most Recently Shared on May 8, 2010 at 4:52 pm By:
Medscape Pathology Health Site
(Path) Prostatic Stromal Sarcoma: eMedicine Pathology -- http://bit.ly/bjUhC4
Oncology Article | sarcoma
mdlinx.com — “Long-term medroxyprogesterone acetate therapy for low-grade endometrial stromal sarcoma” View full resource at mdlinx.com
Most Recently Shared on August 16, 2011 at 1:36 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Long-term medroxyprogesterone acetate therapy for low-grade endometrial stromal sarcoma: International... http://t.co/SbkL740 #oncology
The Inside Mystery of Jejunal Gastrointestinal Stromal Tumor: A Rare Case Report and Review of the Literature
hindawi.com — “Gastrointestinal stromal tumors (GISTs) are malignant and rare form of soft tissue sarcoma of the digestive tract. The incidence of gastrointestinal stromal tumors is very low Kramer et al. 2005 Jejunal GISTs are extremely rare. Here we present a rare case of jejunal GIST with unusually large size at presentation. The patient presented with severe abdomen pain, exophytic growth, and dimorphic anemia. Surgical resection of the tumor was carried out, and operative findings revealed a 15 × 10?cm gr” View full resource at hindawi.com
Most Recently Shared on July 3, 2011 at 10:21 pm By:
The Inside Mystery of Jejunal Gastrointestinal Stromal Tumor: A Rare Case Report and Review of the Literature: G... http://bit.ly/jkmb85
FDA ODAC votes in favour of GSK's Votrient
news-medical.net — “GlaxoSmithKline announced today that the Oncologic Drugs Advisory Committee (ODAC) to the US FDA voted 11 to 2 that evidence from clinical studies support a favourable benefit – risk assessment for use of Votrient in treating patients with advanced soft tissue sarcoma who have received prior chemotherapy, noting that those with gastrointestinal stromal tumours (GIST) and adipocytic sarcomas were not included in the Phase III trial.” View full resource at news-medical.net
Most Recently Shared on March 21, 2012 at 10:23 am By:
FDA ODAC votes in favour of GSK's Votrient: GlaxoSmithKline announced today that the Oncologic Drugs Advisory Co... http://t.co/1qoZMRxM
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Medscape Pathology
Latest medical news, articles, and features from Medscape Pathology.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
OrganizedWisdom GI
Organizing gastroenterology and digestion resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
